Recent Updates
Recently added Catalysts
ALT

Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity

Key Takeaway: Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity

Full Press Release Details

Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity.
Last updated: Jan 31, 2022